CORRECTION article

Front. Pharmacol., 09 June 2025

Sec. Cardiovascular and Smooth Muscle Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1633008

Correction: Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms

  • 1. Children’s Heart Center, Institute of Cardiovascular Development and Translational Medicine, The Second Affiliated Hospital and Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou, China

  • 2. Department of Anesthesiology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • 3. Department of Thoracic and Cardiovascular Surgery, Shanghai Children’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • 4. Department of Thoracic and Cardiovascular Surgery, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • 5. Department of Pediatric Intensive Care Unit, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • 6. Shanghai Institute For Pediatric Congenital Heart Disease, Shanghai Children’s Medical Center, School of Medicine Shanghai Jiao Tong University, Shanghai, China

  • 7. Department of Cardiology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Article metrics

View details

984

Views

240

Downloads

In the published article, there was an error in the affiliations. The order of affiliations 1 and 2 was inverted.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

sterofundin, electrolyte solutions, myocardium infarction, intensive care, autophagy

Citation

Chen M, Xiao Y, Zheng J, Zhao P, Cheng L, Jiang C, Zheng S, Wang Z, Sun S, Ye L, Chen G, Zhang H and Huang Y (2025) Correction: Cardioprotective effects of the electrolyte solution sterofundin and the possible underlying mechanisms. Front. Pharmacol. 16:1633008. doi: 10.3389/fphar.2025.1633008

Received

22 May 2025

Accepted

23 May 2025

Published

09 June 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

16 - 2025

Updates

Copyright

*Correspondence: Guozhen Chen, ; Lincai Ye, ; Hao Zhang, ; Yanhui Huang,

†These authors have contributed equally to this work

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics